Skip to main content
. Author manuscript; available in PMC: 2015 Oct 24.
Published in final edited form as: Mol Neurobiol. 2013 Dec 3;49(3):1282–1292. doi: 10.1007/s12035-013-8598-0

Fig. 6.

Fig. 6

Ceftriaxone attenuates tyrosine hydroxylase (TH) loss in 6-OHDA lesioned rats. a Seven consecutive daily injections intraperitoneally of (200 mg/kg) ceftriaxone starting on the day of 6-OHDA infusion attenuated TH loss by ~30 % in 4–8-month-old male Sprague–Dawley rats, as compared to an average TH loss of vehicle Treated rats was 86 % (n =9, paired t test, t =5.24, p <0.05). b Representative Western blot of a (left to right): ceftriaxone-treated rat [lesion (L), unlesioned (UL)] and a vehicle treated rat. Standards of TH shown in nanograms (0.5, 2, 3, and 4)